Literature DB >> 27421617

Effects of Telephone-Delivered Cognitive-Behavioral Therapy and Nondirective Supportive Therapy on Sleep, Health-Related Quality of Life, and Disability.

Gretchen A Brenes1, Suzanne C Danhauer2, Mary F Lyles3, Andrea Anderson4, Michael E Miller4.   

Abstract

OBJECTIVES: The purpose of this study was to compare the effects of cognitive-behavioral therapy delivered by telephone (CBT-T) and telephone-delivered nondirective supportive therapy (NST-T) on sleep, health-related quality of life, and physical disability in rural older adults with generalized anxiety disorder.
METHODS: This was a secondary analysis of a randomized clinical trial on 141 rural-dwelling adults 60 years and older diagnosed with generalized anxiety disorder. Sleep was assessed with the Insomnia Severity Index. Health-related quality of life was assessed with the 36-item Short-Form Health Survey (SF-36). Physical disability was assessed with the Pepper Center Tool for Disability. Assessments occurred at baseline, 4 months, 9 months, and 15 months.
RESULTS: Insomnia declined in both groups from baseline to 4 months, with a significantly greater improvement among participants who received CBT-T. Similarly, Mental and Physical Component Summaries of the SF-36 declined in both groups, with a differential effect favoring CBT-T. Participants in both interventions reported declines in physical disability, although there were no significant differences between the two interventions. Improvements in insomnia were maintained at the 15-month assessment, whereas between-group differences shrank on the Mental and Physical Component Summaries of the SF-36 by the 15-month assessment.
CONCLUSION: CBT-T was superior to NST-T in reducing insomnia and improving health-related quality of life. The effects of CBT-T on sleep were maintained 1 year after completing the treatment.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive-behavioral therapy; GAD; RCT; late-life anxiety; psychotherapy; supportive therapy

Mesh:

Year:  2016        PMID: 27421617      PMCID: PMC5026974          DOI: 10.1016/j.jagp.2016.04.002

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  28 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

2.  Insomnia and incident depression: role of objective sleep duration and natural history.

Authors:  Julio Fernandez-Mendoza; Sarah Shea; Alexandros N Vgontzas; Susan L Calhoun; Duanping Liao; Edward O Bixler
Journal:  J Sleep Res       Date:  2015-02-27       Impact factor: 3.981

3.  Metabolic syndrome, major depression, generalized anxiety disorder, and ten-year all-cause and cardiovascular mortality in middle aged and elderly patients.

Authors:  Jurate Butnoriene; Adomas Bunevicius; Ausra Saudargiene; Charles B Nemeroff; Antanas Norkus; Vile Ciceniene; Robertas Bunevicius
Journal:  Int J Cardiol       Date:  2015-04-16       Impact factor: 4.164

4.  Assessing performance-related disability in patients with knee osteoarthritis.

Authors:  W J Rejeski; W H Ettinger; S Schumaker; P James; R Burns; J T Elam
Journal:  Osteoarthritis Cartilage       Date:  1995-09       Impact factor: 6.576

5.  Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder.

Authors:  T D Borkovec; E Costello
Journal:  J Consult Clin Psychol       Date:  1993-08

6.  Prevalence and correlates of generalized anxiety disorder in a national sample of older adults.

Authors:  Corey S Mackenzie; Kristin Reynolds; Kee-Lee Chou; Jina Pagura; Jitender Sareen
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

7.  A component analysis of cognitive-behavioral therapy for generalized anxiety disorder and the role of interpersonal problems.

Authors:  T D Borkovec; Michelle G Newman; Aaron L Pincus; Richard Lytle
Journal:  J Consult Clin Psychol       Date:  2002-04

8.  Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study.

Authors:  Elisabeth J Martens; Peter de Jonge; Beeya Na; Beth E Cohen; Heather Lett; Mary A Whooley
Journal:  Arch Gen Psychiatry       Date:  2010-07

9.  Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder: A Randomized Clinical Trial.

Authors:  Gretchen A Brenes; Suzanne C Danhauer; Mary F Lyles; Patricia E Hogan; Michael E Miller
Journal:  JAMA Psychiatry       Date:  2015-10       Impact factor: 21.596

10.  Association between sleep and physical function in older men: the osteoporotic fractures in men sleep study.

Authors:  Thuy-Tien L Dam; Susan Ewing; Sonia Ancoli-Israel; Kristine Ensrud; Susan Redline; Katie Stone
Journal:  J Am Geriatr Soc       Date:  2008-08-25       Impact factor: 5.562

View more
  4 in total

1.  Insomnia in Older Adults.

Authors:  Vivian Nguyen; Tessy George; Glenna S Brewster
Journal:  Curr Geriatr Rep       Date:  2019-10-22

Review 2.  Assessing the Efficacy of Mobile Health Apps Using the Basic Principles of Cognitive Behavioral Therapy: Systematic Review.

Authors:  Amy Leigh Rathbone; Laura Clarry; Julie Prescott
Journal:  J Med Internet Res       Date:  2017-11-28       Impact factor: 5.428

3.  The Efficacy of a Smartphone-Based App on Stress Reduction: Randomized Controlled Trial.

Authors:  Hyunchan Hwang; Sun Mi Kim; Bo Netterstrøm; Doug Hyun Han
Journal:  J Med Internet Res       Date:  2022-02-15       Impact factor: 7.076

4.  Effectiveness and cost-effectiveness of telephone-based cognitive-behavioural therapy in primary care: study protocol of TIDe - telephone intervention for depression.

Authors:  Birgit Watzke; Elisa Haller; Maya Steinmann; Daniela Heddaeus; Martin Härter; Hans-Helmut König; Karl Wegscheider; Thomas Rosemann
Journal:  BMC Psychiatry       Date:  2017-07-19       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.